Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Eicosapentaenoic acid 170mg/Docosahexaenoic acid 115mg caps
0212000V0AAABAB
|
EPA/DHA | Omega-3 marine triglycerides | Cardiovascular System | No data available |
|
Elantan 10 tablets
0206010K0BBAAAB
|
Elantan | Isosorbide mononitrate | Cardiovascular System | No data available |
|
Elantan 20 tablets
0206010K0BBABAC
|
Elantan | Isosorbide mononitrate | Cardiovascular System | No data available |
|
Elantan 40 tablets
0206010K0BBACAD
|
Elantan | Isosorbide mononitrate | Cardiovascular System | No data available |
|
Elmiron 100mg capsules (Imported)
0208020I0BEABAG
|
Elmiron | Pentosan polysulfate sodium | Cardiovascular System | No data available |
|
Elmiron 100mg capsules (Teva)
0208020I0BEAAAG
|
Elmiron | Pentosan polysulfate sodium | Cardiovascular System | No data available |
|
Emcor 10mg tablets
0204000H0BCABAB
|
Emcor | Bisoprolol fumarate | Cardiovascular System | No data available |
|
Emcor LS 5mg tablets
0204000H0BCAAAA
|
Emcor | Bisoprolol fumarate | Cardiovascular System | No data available |
|
Enalapril 1.2mg/5ml oral liquid
0205051I0AABTBT
|
Enalapril maleate | Enalapril maleate | Cardiovascular System | No data available |
|
Enalapril 1.5mg/5ml oral liquid
0205051I0AABSBS
|
Enalapril maleate | Enalapril maleate | Cardiovascular System | No data available |
|
Enalapril 12.5mg/5ml oral liquid
0205051I0AABLBL
|
Enalapril maleate | Enalapril maleate | Cardiovascular System | No data available |
|
Enalapril 15mg/5ml oral liquid
0205051I0AABNBN
|
Enalapril maleate | Enalapril maleate | Cardiovascular System | No data available |
|
Enalapril 1mg orodispersible tablets sugar free
0205051I0AACECE
|
Enalapril maleate | Enalapril maleate | Cardiovascular System | No data available |
|
Enalapril 1mg/5ml oral liquid
0205051I0AAASAS
|
Enalapril maleate | Enalapril maleate | Cardiovascular System | No data available |
|
Enalapril 2.5mg/5ml oral liquid
0205051I0AAAJAJ
|
Enalapril maleate | Enalapril maleate | Cardiovascular System | No data available |
|
Enalapril 20mg/5ml oral liquid
0205051I0AAAPAP
|
Enalapril maleate | Enalapril maleate | Cardiovascular System | No data available |
|
Enalapril 25mg/5ml oral liquid
0205051I0AABBBB
|
Enalapril maleate | Enalapril maleate | Cardiovascular System | No data available |
|
Enalapril 2mg/5ml oral liquid
0205051I0AAAWAW
|
Enalapril maleate | Enalapril maleate | Cardiovascular System | No data available |
|
Enalapril 3.5mg/5ml oral liquid
0205051I0AAATAT
|
Enalapril maleate | Enalapril maleate | Cardiovascular System | No data available |
|
Enalapril 3.75mg/5ml oral liquid
0205051I0AAAXAX
|
Enalapril maleate | Enalapril maleate | Cardiovascular System | No data available |
|
Enalapril 3mg/5ml oral liquid
0205051I0AAAYAY
|
Enalapril maleate | Enalapril maleate | Cardiovascular System | No data available |
|
Enalapril 40mg/5ml oral liquid
0205051I0AABVBV
|
Enalapril maleate | Enalapril maleate | Cardiovascular System | No data available |
|
Enalapril 4mg/5ml oral liquid
0205051I0AAAZAZ
|
Enalapril maleate | Enalapril maleate | Cardiovascular System | No data available |
|
Enalapril 500micrograms/5ml oral liquid
0205051I0AAAVAV
|
Enalapril maleate | Enalapril maleate | Cardiovascular System | No data available |
|
Enalapril 600micrograms/5ml oral liquid
0205051I0AAARAR
|
Enalapril maleate | Enalapril maleate | Cardiovascular System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.